Annual CFF
$5.24 M
-$5.04 M-49.00%
31 December 2022
Summary:
Comera Life Sciences Holdings annual cash flow from financing activities is currently $5.24 million, with the most recent change of -$5.04 million (-49.00%) on 31 December 2022. During the last 3 years, it has risen by +$3.69 million (+237.72%). CMRA annual CFF is now -49.00% below its all-time high of $10.28 million, reached on 31 December 2021.CMRA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$3.21 M
+$3.27 M+5172.15%
30 September 2023
Summary:
Comera Life Sciences Holdings quarterly cash flow from financing activities is currently $3.21 million, with the most recent change of +$3.27 million (+5172.15%) on 30 September 2023. CMRA quarterly CFF is now -14.38% below its all-time high of $3.74 million, reached on 30 June 2022.CMRA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$5.85 M
+$3.06 M+109.57%
30 September 2023
Summary:
Comera Life Sciences Holdings TTM cash flow from financing activities is currently $5.85 million, with the most recent change of +$3.06 million (+109.57%) on 30 September 2023. CMRA TTM CFF is now -11.32% below its all-time high of $6.60 million, reached on 31 March 2023.CMRA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMRA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +237.7% | - | - |
| 5 y5 years | - | - | - |
CMRA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -49.0% | +237.7% | -14.4% | +5172.1% | -11.3% | +2530.8% |
| 5 y | 5 years | -49.0% | +237.7% | -14.4% | +5172.1% | -11.3% | +2530.8% |
| alltime | all time | -49.0% | +237.7% | -14.4% | +5172.1% | -11.3% | +2530.8% |
Comera Life Sciences Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $3.21 M(-5172.2%) | $5.85 M(+109.6%) |
| June 2023 | - | -$63.20 K(-104.0%) | $2.79 M(-57.7%) |
| Mar 2023 | - | $1.58 M(+39.8%) | $6.60 M(+25.9%) |
| Dec 2022 | $5.24 M | $1.13 M(+678.7%) | $5.24 M(+27.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $145.20 K(-96.1%) | $4.11 M(+3.7%) |
| June 2022 | - | $3.74 M(+1582.7%) | $3.97 M(+1682.7%) |
| Mar 2022 | - | $222.50 K | $222.50 K |
| Dec 2021 | $10.28 M(+562.2%) | - | - |
| Dec 2020 | $1.55 M | - | - |
FAQ
- What is Comera Life Sciences Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Comera Life Sciences Holdings?
- What is Comera Life Sciences Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Comera Life Sciences Holdings?
- What is Comera Life Sciences Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Comera Life Sciences Holdings?
What is Comera Life Sciences Holdings annual cash flow from financing activities?
The current annual CFF of CMRA is $5.24 M
What is the all time high annual CFF for Comera Life Sciences Holdings?
Comera Life Sciences Holdings all-time high annual cash flow from financing activities is $10.28 M
What is Comera Life Sciences Holdings quarterly cash flow from financing activities?
The current quarterly CFF of CMRA is $3.21 M
What is the all time high quarterly CFF for Comera Life Sciences Holdings?
Comera Life Sciences Holdings all-time high quarterly cash flow from financing activities is $3.74 M
What is Comera Life Sciences Holdings TTM cash flow from financing activities?
The current TTM CFF of CMRA is $5.85 M
What is the all time high TTM CFF for Comera Life Sciences Holdings?
Comera Life Sciences Holdings all-time high TTM cash flow from financing activities is $6.60 M